210 related articles for article (PubMed ID: 16427204)
1. Mammalian expression of full-length bovine aggrecan and link protein: formation of recombinant proteoglycan aggregates and analysis of proteolytic cleavage by ADAMTS-4 and MMP-13.
Miwa HE; Gerken TA; Huynh TD; Flory DM; Hering TM
Biochim Biophys Acta; 2006 Mar; 1760(3):472-86. PubMed ID: 16427204
[TBL] [Abstract][Full Text] [Related]
2. Effects of covalently attached chondroitin sulfate on aggrecan cleavage by ADAMTS-4 and MMP-13.
Miwa HE; Gerken TA; Hering TM
Matrix Biol; 2006 Oct; 25(8):534-45. PubMed ID: 16945513
[TBL] [Abstract][Full Text] [Related]
3. Glycosaminoglycan-binding properties and aggrecanase activities of truncated ADAMTSs: comparative analyses with ADAMTS-5, -9, -16 and -18.
Zeng W; Corcoran C; Collins-Racie LA; Lavallie ER; Morris EA; Flannery CR
Biochim Biophys Acta; 2006 Mar; 1760(3):517-24. PubMed ID: 16507336
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation.
Little CB; Hughes CE; Curtis CL; Janusz MJ; Bohne R; Wang-Weigand S; Taiwo YO; Mitchell PG; Otterness IG; Flannery CR; Caterson B
Matrix Biol; 2002 Apr; 21(3):271-88. PubMed ID: 12009333
[TBL] [Abstract][Full Text] [Related]
5. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
[TBL] [Abstract][Full Text] [Related]
6. Variations in aggrecan structure modulate its susceptibility to aggrecanases.
Roughley PJ; Barnett J; Zuo F; Mort JS
Biochem J; 2003 Oct; 375(Pt 1):183-9. PubMed ID: 12859252
[TBL] [Abstract][Full Text] [Related]
7. Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4).
Tortorella MD; Pratta M; Liu RQ; Austin J; Ross OH; Abbaszade I; Burn T; Arner E
J Biol Chem; 2000 Jun; 275(24):18566-73. PubMed ID: 10751421
[TBL] [Abstract][Full Text] [Related]
8. MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover.
Struglics A; Hansson M
Biochem J; 2012 Sep; 446(2):213-23. PubMed ID: 22670872
[TBL] [Abstract][Full Text] [Related]
9. MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein.
Durigova M; Nagase H; Mort JS; Roughley PJ
Matrix Biol; 2011 Mar; 30(2):145-53. PubMed ID: 21055468
[TBL] [Abstract][Full Text] [Related]
10. Roles of aggrecan domains in biosynthesis, modification by glycosaminoglycans and product secretion.
Kiani C; Lee V; Cao L; Chen L; Wu Y; Zhang Y; Adams ME; Yang BB
Biochem J; 2001 Feb; 354(Pt 1):199-207. PubMed ID: 11171095
[TBL] [Abstract][Full Text] [Related]
11. The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage.
Tortorella M; Pratta M; Liu RQ; Abbaszade I; Ross H; Burn T; Arner E
J Biol Chem; 2000 Aug; 275(33):25791-7. PubMed ID: 10827174
[TBL] [Abstract][Full Text] [Related]
12. Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing.
Kashiwagi M; Enghild JJ; Gendron C; Hughes C; Caterson B; Itoh Y; Nagase H
J Biol Chem; 2004 Mar; 279(11):10109-19. PubMed ID: 14662755
[TBL] [Abstract][Full Text] [Related]
13. Regulation of aggrecanases from the ADAMTS family and aggrecan neoepitope formation during in vitro chondrogenesis of human mesenchymal stem cells.
Boeuf S; Graf F; Fischer J; Moradi B; Little CB; Richter W
Eur Cell Mater; 2012 May; 23():320-32. PubMed ID: 22562232
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the interglobular domain of aggrecan alter matrix metalloproteinase and aggrecanase cleavage patterns. Evidence that matrix metalloproteinase cleavage interferes with aggrecanase activity.
Mercuri FA; Maciewicz RA; Tart J; Last K; Fosang AJ
J Biol Chem; 2000 Oct; 275(42):33038-45. PubMed ID: 11032846
[TBL] [Abstract][Full Text] [Related]
15. ADAMTS-4_v1 is a splice variant of ADAMTS-4 that is expressed as a protein in human synovium and cleaves aggrecan at the interglobular domain.
Wainwright SD; Bondeson J; Caterson B; Hughes CE
Arthritis Rheum; 2013 Nov; 65(11):2866-75. PubMed ID: 23897278
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human aggrecan G1-G2 exhibits native binding properties and substrate specificity for matrix metalloproteinases and aggrecanase.
Mercuri FA; Doege KJ; Arner EC; Pratta MA; Last K; Fosang AJ
J Biol Chem; 1999 Nov; 274(45):32387-95. PubMed ID: 10542281
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies directed against epitopes within the core protein structure of the large aggregating proteoglycan (aggrecan) from the swarm rat chondrosarcoma.
Calabro A; Hascall VC; Caterson B
Arch Biochem Biophys; 1992 Nov; 298(2):349-60. PubMed ID: 1384430
[TBL] [Abstract][Full Text] [Related]
18. Mature bovine articular cartilage contains abundant aggrecan that is C-terminally truncated at Ala719-Ala720, a site which is readily cleaved by m-calpain.
Oshita H; Sandy JD; Suzuki K; Akaike A; Bai Y; Sasaki T; Shimizu K
Biochem J; 2004 Aug; 382(Pt 1):253-9. PubMed ID: 15175011
[TBL] [Abstract][Full Text] [Related]
19. Degradation of cartilage aggrecan by collagenase-3 (MMP-13).
Fosang AJ; Last K; Knäuper V; Murphy G; Neame PJ
FEBS Lett; 1996 Feb; 380(1-2):17-20. PubMed ID: 8603731
[TBL] [Abstract][Full Text] [Related]
20. Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan.
Büttner FH; Hughes CE; Margerie D; Lichte A; Tschesche H; Caterson B; Bartnik E
Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):159-65. PubMed ID: 9639575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
